Anti-herpesviral activity of curcumin may attenuate the development of Alzheimer's disease

被引:3
|
作者
Mori, Isamu [1 ]
机构
[1] Shubun Univ, Fac Hlth & Nutr, Ichinomiya, Aichi 4910938, Japan
关键词
EXPRESSION;
D O I
10.1016/j.mehy.2015.03.014
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:603 / 603
页数:1
相关论文
共 50 条
  • [21] Chocolate may attenuate cognitive deterioration in Alzheimer's disease through prevention of gene expression related to depressive disorder
    Pasinetti, Giulio Maria
    FASEB JOURNAL, 2013, 27
  • [22] NSAIDs may not prevent Alzheimer's disease
    不详
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (06) : 785 - 785
  • [23] Alzheimer's disease prevalence may quadruple
    Larkin, M
    LANCET, 1998, 352 (9132): : 965 - 965
  • [24] PFASs May Risk Alzheimer's Disease
    Wang, He-Ling
    Fang, Evandro F.
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2024, 79 (03):
  • [26] The impact of curcumin and its modified formulations on Alzheimer's disease
    Farkhondeh, Tahereh
    Samarghandian, Saeed
    Pourbagher-Shahri, Ali Mohammad
    Sedaghat, Mahshid
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (10) : 16953 - 16965
  • [27] Curcumin/melatonin hybrids as neuroprotective agents for Alzheimer's disease
    Saathoff, John
    Liu, Kai
    Chojnacki, Jeremy
    Zhang, Shijun
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
  • [28] Use of curcumin in diagnosis, prevention, and treatment of Alzheimer's disease
    Chen, Min
    Du, Zhi-Yun
    Zheng, Xi
    Li, Dong-Li
    Zhou, Ren-Ping
    Zhang, Kun
    NEURAL REGENERATION RESEARCH, 2018, 13 (04) : 742 - 752
  • [29] Curcumin–pluronic nanoparticles: A theranostic nanoformulation for alzheimer’s disease
    Singh A.
    Mahajan S.D.
    Kutscher H.L.
    Kim S.
    Prasad P.N.
    Critical Reviews in Biomedical Engineering, 2020, 48 (03) : 153 - 168
  • [30] The Current Evidence for the Therapeutic Role of Curcumin in Alzheimer's Disease
    Bland, Abigail R.
    Ashton, John C.
    Kamal, Mohammad Amjad
    Sahebkar, Amirhossein
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2023, 22 (03) : 318 - 320